Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)
We are collecting clinical notes and results of imaging studies (CT and PET scans) from referring physicians who follow the clinical status of patients treated with radiofrequency ablation (RFA). The research objective is to determine whether the patients with (RFA) remain alive, and whether they are in remission or have progressive/ recurrent malignancy
Checked against the public recordLast updated Dec 15, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- State University of New York - Upstate Medical University
- Interventions being studied
- Device: Radiofrequency ablation
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients with lung masses * Patients who consent to radiofrequency ablation of mass
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Upstate Medical UniversitySyracuse, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 15, 2023. Always confirm current availability with the study team.